David D. Dore

Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States

Anthony P. Nunes, A. Nunes, Anita M. Loughlin, 2018, Diabetes Spectrum.

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

David D. Dore, John D. Seeger, D. Dore, 2009, Current medical research and opinion.